AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 100 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,085,027 | -42.5% | 170,067 | 0.0% | 0.01% | -42.9% |
Q2 2023 | $1,886,043 | -21.5% | 170,067 | 0.0% | 0.01% | -17.6% |
Q1 2023 | $2,402,806 | -48.7% | 170,067 | -19.4% | 0.02% | -46.9% |
Q4 2022 | $4,683,357 | +35.9% | 211,067 | 0.0% | 0.03% | +33.3% |
Q3 2022 | $3,447,000 | +12.4% | 211,067 | 0.0% | 0.02% | -4.0% |
Q2 2022 | $3,067,000 | +3.8% | 211,067 | +31.9% | 0.02% | +25.0% |
Q1 2022 | $2,955,000 | -22.3% | 159,988 | 0.0% | 0.02% | -16.7% |
Q4 2021 | $3,803,000 | -2.6% | 159,988 | +0.9% | 0.02% | -11.1% |
Q3 2021 | $3,906,000 | -1.2% | 158,588 | -0.9% | 0.03% | 0.0% |
Q2 2021 | $3,953,000 | +727.0% | 159,988 | +720.6% | 0.03% | +575.0% |
Q1 2021 | $478,000 | -4.0% | 19,497 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $498,000 | -11.5% | 19,497 | -2.5% | 0.00% | -20.0% |
Q3 2020 | $563,000 | -0.4% | 20,000 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $565,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |